The Oncology Institute, Inc.TOIIWNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank61
3Y CAGR-61.2%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-61.2%/yr
Quarterly compound
Percentile
P61
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 2.97% |
| Q2 2025 | 13.15% |
| Q1 2025 | -48.57% |
| Q4 2024 | 18.19% |
| Q3 2024 | -4.10% |
| Q2 2024 | 22.17% |
| Q1 2024 | -6.05% |
| Q4 2023 | -7.66% |
| Q3 2023 | -3.09% |
| Q2 2023 | 43.67% |
| Q1 2023 | -172.54% |
| Q4 2022 | -311.63% |
| Q3 2022 | 50.96% |
| Q2 2022 | -128.27% |
| Q1 2022 | 289.90% |
| Q4 2021 | -240.81% |
| Q3 2021 | -192.98% |
| Q2 2021 | 421.79% |
| Q1 2021 | 79.33% |
| Q4 2020 | -612.92% |
| Q3 2020 | -166.39% |
| Q2 2020 | 110.34% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |